Bilosomal glibenclamide gel formulation for enhanced bioavailability in the brain, comprises glibenclamide, sodium deoxycholate, mixture of cholesterol and sorbitan monopalmitate
	TRIPATHI M; KAURAV H
	2023-09-14
专利权人	UNIV SHOOLINI BIOTECHNOLOGY & MANAGEMENT (USLN-C)
申请日期	2023-09-14
专利号	IN202311061902-A
成果简介	NOVELTY - Bilosomal glibenclamide gel formulation comprises 3 mg glibenclamide, 5-25 mg sodium deoxycholate, 100-300 mg mixture of cholesterol and Span(RTM: Sorbitan monopalmitate) 40 in a weight ratio of 1:1-1:9. USE - Bilosomal glibenclamide gel formulation for enhanced bioavailability in the brain. ADVANTAGE - The bilosomal glibenclamide gel formulation exhibits a drug release efficiency of 86.54% at 12 hours, and exhibits an entrapped efficiency of 35-70%, and holds immense potential in advancing neurological therapies.
IPC 分类号	A61K-031/4375 ; A61K-031/475 ; A61K-031/64 ; A61K-047/10 ; A61K-047/26 ; A61K-009/00 ; A61K-009/127
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/20397
专题	中国科学院新疆生态与地理研究所
作者单位	UNIV SHOOLINI BIOTECHNOLOGY & MANAGEMENT (USLN-C)
推荐引用方式 GB/T 7714	TRIPATHI M,KAURAV H. Bilosomal glibenclamide gel formulation for enhanced bioavailability in the brain, comprises glibenclamide, sodium deoxycholate, mixture of cholesterol and sorbitan monopalmitate. IN202311061902-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。